Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells

BACKGROUND: Vascular endothelial growth factor-a (VEGF)-targeted therapies have become an important treatment for a number of human malignancies. The VEGF inhibitors are actually effective in several types of cancers, however, the benefits are transiently, and the vast majority of patients who initi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamagishi, Naoko, Teshima-Kondo, Shigetada, Masuda, Kiyoshi, Nishida, Kensei, Kuwano, Yuki, Dang, Duyen T, Dang, Long H, Nikawa, Takeshi, Rokutan, Kazuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658959/
https://www.ncbi.nlm.nih.gov/pubmed/23651517
http://dx.doi.org/10.1186/1471-2407-13-229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658959/
https://www.ncbi.nlm.nih.gov/pubmed/23651517
http://dx.doi.org/10.1186/1471-2407-13-229

Ejemplares similares